MSFT vs ROP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and stability. While the stock trades at a significant premium to its Graham Number ($138.23), it remains below its growth-based intrinsic value of $476.13, suggesting reasonable upside. Exceptional earnings growth (59.8% YoY) and elite profit margins (39.04%) outweigh current bearish technical trends and insider selling. The company's consistent track record of beating earnings estimates over 25 quarters reinforces a strong long-term outlook.
ROP presents a compelling investment case despite near-term price underperformance, trading at a significant discount to its $573.87 analyst target price with strong fundamentals intact. The company demonstrates consistent earnings execution, beating estimates in 3 of the last 4 quarters and delivering double-digit YoY EPS growth of 11.3%, underpinned by best-in-class margins (68.96% gross, 28.40% operating). While insider selling raises caution, it appears opportunistic rather than strategic, and the stock remains deeply undervalued relative to both its growth trajectory and the broader technology sector’s sky-high valuation multiples. ROP’s disciplined capital allocation, low leverage, and durable software-driven business model position it well for re-rating as macro sentiment improves.
Compare Another Pair
Related Comparisons
MSFT vs ROP: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and Roper Technologies, Inc. (ROP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.